US Supreme Court permits mail-order access to abortion pill mifepristone

Here is a rewritten version of the news article in a neutral newsroom style:

The US Supreme Court has allowed the continued availability of mifepristone, an abortion pill distributed by mail, pending the outcome of a lawsuit. The court’s decision means that patients can still access the medication through telehealth services and mail distribution.

Mifepristone is widely used to induce abortion in the first trimester. In 2020, the FDA approved the medication for emergency use during pregnancy. However, some states have restricted its availability due to concerns over safety and efficacy.

The Supreme Court’s decision comes as a lawsuit challenges the FDA’s approval of mifepristone. The lawsuit argues that the agency did not follow proper procedures when approving the medication. The court’s ruling allows the lawsuit to proceed while also preserving access to mifepristone for patients who need it.

Telehealth services and mail distribution have been used by some pharmacies to provide mifepristone to patients in states where the medication is restricted. The Supreme Court’s decision does not address these methods, but rather allows them to continue pending the outcome of the lawsuit.

The court’s ruling is seen as a temporary measure, and it remains to be seen how the lawsuit will ultimately affect access to mifepristone.

Source: Google News World